Recruiting OBSERVATIONAL NCT07360418
Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial. (SCANX)
A Prospective Multicenter Study Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial
Sponsor: Applied Biologics, LLC
Interventions
Blue Drop Foot Scanner
Updated 1 time since 2026 Last updated: Feb 9, 2026 Started: Oct 16, 2025 Primary completion: Oct 31, 2027 Completion: Oct 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07360418, this observational or N/A phase trial focuses on Diabetic Foot Ulcer and Diabetic Foot Ulcers (DFU) and remains actively recruiting participants. Sponsored by Applied Biologics, LLC, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Applied Biologics, LLC
- Serena Group
Data source: Applied Biologics, LLC
For direct contact, visit the study record on ClinicalTrials.gov .